SCHEDULE: Coya Therapeutics Stakeholder Discloses Holdings

A Schedule 13G filing reveals Orin Hirschman and AIGH Capital Management LLC's beneficial ownership of Coya Therapeutics, Inc. common stock.

Summary

• Orin Hirschman and AIGH Capital Management LLC have jointly filed a Schedule 13G, indicating their beneficial ownership of Coya Therapeutics, Inc. common stock.
• Orin Hirschman beneficially owns 764,679 shares, representing 3.3% of the class of securities.
• AIGH Capital Management LLC beneficially owns 631,912 shares, representing 2.7% of the class of securities.
• The filing indicates that Orin Hirschman is the Managing Member of AIGH Capital Management LLC and president of AIGH LLC.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance updates.

Positives

• Disclosure of significant beneficial ownership by investment entities and an individual, providing transparency to the market.
• The filing confirms that the shares were acquired and are held in the ordinary course of business, suggesting stable investment rather than activist intent.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors and significant individual holders, indicating passive investment stakes rather than active control attempts. This filing provides transparency regarding the holdings of Orin Hirschman and AIGH Capital Management LLC in Coya Therapeutics, Inc.

Stakeholder Impact

• Shareholders gain clarity on the ownership structure and the passive investment intent of significant holders.
• The market receives updated information on the beneficial ownership percentages held by Orin Hirschman and AIGH Capital Management LLC.

Key Dates

Keywords

Coya Therapeutics, Schedule 13G, Beneficial Ownership, Orin Hirschman, AIGH Capital Management, Common Stock, SEC Filing